A Randomised Controlled Trial to Investigate the Effects of a Mindfulness Smartphone App on Well-being in the Workplace
- Conditions
- Well-being, Work Stress
- Interventions
- Other: Headspace On-the-go app
- Registration Number
- NCT01661569
- Lead Sponsor
- University College, London
- Brief Summary
We propose a randomised controlled trial in a workplace setting to investigate whether a smartphone-delivered programme of mindfulness meditation influences psychological and biological indicators of well-being.
We hypothesise that after 8 weeks participants who complete the meditation programme will show increases in psychological well-being and reduced activation of stress-related biological pathways.
- Detailed Description
Mindfulness-based therapies can reduce depressive symptoms in patients and healthy subjects. Therapies such as MBSR (mindfulness-based stress reduction) typically consist of 8 group sessions led by an experienced practitioner, plus home practice and one full day of meditation. In this study we aim to investigate whether a mindfulness programme delivered as a series of podcasts on a mobile phone app could lead to gains in well-being and a reduction in stress.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
- Employees of a UK high-tech company
- Raised levels of work stress (overcommitment>2) or depression (CESD>1)
- treated for anxiety, depression or hypertension
- taking medication containing steroids
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Headspace On-the-go app Headspace On-the-go app Participants were given access to a 45-day mindfulness meditation programme via the Headspace smartphone app
- Primary Outcome Measures
Name Time Method Well-being 8 weeks Psychological well-being will be assessed using the Warwick Edinburgh Mental Well-Being Scale
- Secondary Outcome Measures
Name Time Method Blood pressure 8 weeks Blood pressure over the working day will be measured as an indicator of activation of the stress response
Trial Locations
- Locations (1)
UK high-tech company office
🇬🇧London, United Kingdom